PT1169442E - Polipeptidos segregados e transmembranares e acidos nucleicos que os codificam - Google Patents

Polipeptidos segregados e transmembranares e acidos nucleicos que os codificam

Info

Publication number
PT1169442E
PT1169442E PT00917717T PT00917717T PT1169442E PT 1169442 E PT1169442 E PT 1169442E PT 00917717 T PT00917717 T PT 00917717T PT 00917717 T PT00917717 T PT 00917717T PT 1169442 E PT1169442 E PT 1169442E
Authority
PT
Portugal
Prior art keywords
polypeptides
present
polypseptides
transmembrane
encode
Prior art date
Application number
PT00917717T
Other languages
English (en)
Inventor
Desnoyers Luc
Dan L Eaton
Goddard Audrey
Paul J Godowski
Austin L Gurney
James Pan
Timothy A Stewart
Colin K Watanabe
William I Wood
Zhang Zemin
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of PT1169442E publication Critical patent/PT1169442E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
PT00917717T 1999-03-23 2000-03-01 Polipeptidos segregados e transmembranares e acidos nucleicos que os codificam PT1169442E (pt)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US12577499P 1999-03-23 1999-03-23
US12577899P 1999-03-23 1999-03-23
US12582699P 1999-03-24 1999-03-24
US12703599P 1999-03-31 1999-03-31
US12770699P 1999-04-05 1999-04-05
US13035999P 1999-04-21 1999-04-21
US13129199P 1999-04-27 1999-04-27
US13127299P 1999-04-27 1999-04-27
US13127099P 1999-04-27 1999-04-27
US13237199P 1999-05-04 1999-05-04
US13238399P 1999-05-04 1999-05-04
US13237999P 1999-05-04 1999-05-04
US13575099P 1999-05-25 1999-05-25
US13816699P 1999-06-08 1999-06-08
US14479199P 1999-07-20 1999-07-20
US14697099P 1999-08-03 1999-08-03
US17026299P 1999-12-09 1999-12-09

Publications (1)

Publication Number Publication Date
PT1169442E true PT1169442E (pt) 2006-10-31

Family

ID=27586019

Family Applications (3)

Application Number Title Priority Date Filing Date
PT05014619T PT1609863E (pt) 1999-03-23 2000-03-01 Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam
PT00917717T PT1169442E (pt) 1999-03-23 2000-03-01 Polipeptidos segregados e transmembranares e acidos nucleicos que os codificam
PT05011885T PT1616878E (pt) 1999-03-23 2000-03-01 Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT05014619T PT1609863E (pt) 1999-03-23 2000-03-01 Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT05011885T PT1616878E (pt) 1999-03-23 2000-03-01 Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam

Country Status (11)

Country Link
EP (4) EP1169442B1 (pt)
JP (8) JP4174183B2 (pt)
KR (1) KR100504305B1 (pt)
AT (4) ATE417063T1 (pt)
AU (1) AU764092B2 (pt)
CA (1) CA2361221A1 (pt)
DK (3) DK1609863T3 (pt)
ES (3) ES2269125T3 (pt)
NZ (3) NZ536320A (pt)
PT (3) PT1609863E (pt)
WO (1) WO2000056889A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US20030036114A1 (en) 1998-05-15 2003-02-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU778759B2 (en) * 1998-12-23 2004-12-16 Genentech Inc. IL-1 related polypeptides
DE60041333D1 (de) * 1999-08-12 2009-02-26 Agensys Inc Hen prostatkrebs exprimiert wird, und deren verwendungen
US7842458B2 (en) 1999-08-12 2010-11-30 Agensys, Inc. Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
AU784727B2 (en) * 2000-02-08 2006-06-01 Amgen, Inc. IL-17 like molecules and uses thereof
US7067297B2 (en) 2000-02-15 2006-06-27 Chugai Seiyaku Kabushiki Kaisha Mannosyltransferase polypeptides and polynucleotides encoding them and methods for making and using them
WO2001062787A1 (en) * 2000-02-24 2001-08-30 Oxford Glycosciences (Uk) Limited Diagnosis and treatment of bipolar affective disorder
AU2001244615A1 (en) * 2000-03-29 2001-10-08 Kyowa Hakko Kogyo Co. Ltd. Proliferative glomerular nephritis-associated gene
JP2004524825A (ja) 2000-12-07 2004-08-19 ザイモジェネティクス，インコーポレイティド 脂肪細胞補体関連タンパク質ｚａｃｒｐ３ｘ２
WO2002053737A1 (fr) * 2000-12-28 2002-07-11 Asahi Kasei Kabushiki Kaisha Gene d'activation de nf-kb
EP1397383A2 (en) * 2001-06-20 2004-03-17 Genentech, Inc. Secreted polypeptide and their use in the treatment of bone disorders
EP1513875A2 (en) * 2002-05-10 2005-03-16 Serono Genetics Institute S.A. Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
WO2003102182A1 (fr) * 2002-05-31 2003-12-11 Hidetoshi Inoko Gene slurp-2 associe a une maladie de peau inflammatoire et utilisation de ce gene
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
DK2069793T3 (en) 2006-08-29 2017-04-24 Oxford Biotherapeutics Ltd IDENTIFICATION OF PROTEIN IN CONNECTION WITH HEPATOCELLULAR CARCINOMA, GLIOBLASTOMA AND LUNG CANCER
DK2403878T3 (en) 2009-03-05 2017-09-18 Squibb & Sons Llc CADM1-SPECIFIC FULLY HUMAN ANTIBODIES
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
KR101695792B1 (ko) * 2014-09-04 2017-01-12 디오셀 주식회사 신규 세포막 투과 펩티드 및 생리활성 물질 전달체로서의 그의 용도

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
US6001970A (en) * 1994-11-07 1999-12-14 Merck & Co., Inc Modified human neuropeptide Y1 Receptors
AU1532697A (en) * 1996-01-12 1997-08-01 Genetics Institute Inc. Beta-chemokine, h1305 (mcp-2)
AU8555198A (en) * 1997-08-01 1999-02-22 Genset 5' ests for secreted proteins expressed in prostate
DE69837761T2 (de) * 1997-08-01 2008-01-17 Serono Genetics Institute S.A. 5' ests für sekretierte proteine aus gehirngeweben
CA2311572A1 (en) * 1997-12-17 1999-06-24 Genset S.A. Extended cdnas for secreted proteins
AU764571B2 (en) * 1998-04-09 2003-08-21 Genset S.A. 5' ESTs and encoded human proteins
AU758074B2 (en) * 1998-04-29 2003-03-13 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use
CA2362423A1 (en) * 1998-12-17 2000-06-22 Human Genome Sciences, Inc. 47 human secreted proteins
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
AU779667B2 (en) * 1999-06-23 2005-02-03 Curagen Corporation Polynucleotides and polypeptides encoded thereby
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
DE60041333D1 (de) * 1999-08-12 2009-02-26 Agensys Inc Hen prostatkrebs exprimiert wird, und deren verwendungen
EP1206536A2 (en) * 1999-08-17 2002-05-22 Sagami Chemical Research Center HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
US6635742B1 (en) * 2000-01-25 2003-10-21 Nuvelo, Inc. Antibodies specific for semaphorin-like polypeptides

Also Published As

Publication number Publication date
JP4392759B2 (ja) 2010-01-06
JP2006101881A (ja) 2006-04-20
DK1169442T3 (da) 2006-10-16
ES2314521T3 (es) 2009-03-16
EP1688430B1 (en) 2009-11-18
EP1169442A2 (en) 2002-01-09
PT1616878E (pt) 2009-03-18
JP4402034B2 (ja) 2010-01-20
EP1616878B1 (en) 2008-12-10
EP1609863A2 (en) 2005-12-28
EP1609863A3 (en) 2006-04-12
ES2319202T3 (es) 2009-05-05
ATE409228T1 (de) 2008-10-15
ATE449108T1 (de) 2009-12-15
JP4392760B2 (ja) 2010-01-06
AU3864800A (en) 2000-10-09
EP1688430A3 (en) 2006-11-02
EP1616878A1 (en) 2006-01-18
PT1609863E (pt) 2009-01-02
WO2000056889A3 (en) 2001-04-26
JP2006158392A (ja) 2006-06-22
DK1616878T3 (da) 2009-03-30
JP2010075189A (ja) 2010-04-08
EP1609863B1 (en) 2008-09-24
JP2006101880A (ja) 2006-04-20
JP4174183B2 (ja) 2008-10-29
JP2006136325A (ja) 2006-06-01
KR100504305B1 (ko) 2005-07-28
EP1688430A2 (en) 2006-08-09
ATE417063T1 (de) 2008-12-15
NZ527292A (en) 2005-03-24
JP2006115848A (ja) 2006-05-11
KR20010112927A (ko) 2001-12-22
AU764092B2 (en) 2003-08-07
ES2269125T3 (es) 2007-04-01
JP2003527074A (ja) 2003-09-16
WO2000056889A2 (en) 2000-09-28
NZ536320A (en) 2006-04-28
JP4398937B2 (ja) 2010-01-13
DK1609863T3 (da) 2008-12-15
EP1169442B1 (en) 2006-06-07
NZ527293A (en) 2005-01-28
CA2361221A1 (en) 2000-09-28
JP2006115847A (ja) 2006-05-11
ATE329023T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
ATE447583T1 (de) Polypeptide und dafür kodierende nukleinsäure
ATE478145T1 (de) Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
PT1169442E (pt) Polipeptidos segregados e transmembranares e acidos nucleicos que os codificam
DK1205546T3 (da) Polypeptider og nucleinsyrer kodende derfor
PT1251173E (pt) Polipeptidos transmembranares e excretados e acidos nucleicos que os codificam
PT1217006E (pt) Polipeptidos e acidos nucleicos que os codificam
PT1207168E (pt) Polipeptidos e acidos nucleicos que os codificam
PT1205550E (pt) Polipeptidos e acidos nucleicos que os codificam
DK1300417T3 (da) Secerneret og transmembrant polypeptid og nucleinsyre kodende derfor
DE69926415D1 (de) Sekretiertes Polypeptide und dafür kodierende Nukleinsäuren
DK1241180T3 (da) Humant A33 antigen-lignende protein og nucleinsyrer, der koder for dette
DK1591452T3 (da) Secernerede og transmembrane polypeptider og nukleinsyrer kodende for samme
DK1241251T3 (da) Humant prostasin-lignende protein og nukleinsyrer kodende for samme
DK1621619T3 (da) Secernerede polypeptider og transmembran-polypeptider og nukleinsyrer, der koder for disse
DK1241183T3 (da) Humant HCAR-agtig protein og nucleinsyrer kodende derfor
PT1191101E (pt) Polipetidos pro241 e acidos nucleidos que codificam os mesmos
DE60043242D1 (de) Ausgeschiedene und transmembrane Polypeptide und dafür kodierende Nukleinsäure
DK1241184T3 (da) Humant synaptogyrin-lignende protein og nukleinsyrer kodende for dette